methyl 3-[[[(dimethylamino)methylene]amino]sulphonyl]-5-nitro-4-phenoxybenzoate
Modify Date: 2025-08-26 06:36:50
![methyl 3-[[[(dimethylamino)methylene]amino]sulphonyl]-5-nitro-4-phenoxybenzoate Structure](https://image.chemsrc.com/caspic/144/60376-73-0.png)
methyl 3-[[[(dimethylamino)methylene]amino]sulphonyl]-5-nitro-4-phenoxybenzoate structure
|
Common Name | methyl 3-[[[(dimethylamino)methylene]amino]sulphonyl]-5-nitro-4-phenoxybenzoate | ||
|---|---|---|---|---|
| CAS Number | 60376-73-0 | Molecular Weight | 407.39800 | |
| Density | 1.36g/cm3 | Boiling Point | 544.9ºC at 760 mmHg | |
| Molecular Formula | C17H17N3O7S | Melting Point | N/A | |
| MSDS | N/A | Flash Point | 283.3ºC | |
| Name | methyl 3-(dimethylaminomethylideneamino)sulfonyl-5-nitro-4-phenoxybenzoate |
|---|---|
| Synonym | More Synonyms |
| Density | 1.36g/cm3 |
|---|---|
| Boiling Point | 544.9ºC at 760 mmHg |
| Molecular Formula | C17H17N3O7S |
| Molecular Weight | 407.39800 |
| Flash Point | 283.3ºC |
| Exact Mass | 407.07900 |
| PSA | 139.47000 |
| LogP | 4.05630 |
| Index of Refraction | 1.595 |
| InChIKey | YPJZKQJKYXBDDW-UHFFFAOYSA-N |
| SMILES | COC(=O)c1cc([N+](=O)[O-])c(Oc2ccccc2)c(S(=O)(=O)N=CN(C)C)c1 |
| HS Code | 2935009090 |
|---|
|
~%
methyl 3-[[[(di... CAS#:60376-73-0 |
| Literature: NEUROTHERAPEUTICS PHARMA, INC.; WANASKI, Stephen; COLLINS, Stephen; KINCAID, John Patent: WO2012/18635 A2, 2012 ; Location in patent: Page/Page column 111 ; WO 2012/018635 A2 |
|
~%
methyl 3-[[[(di... CAS#:60376-73-0 |
| Literature: NEUROTHERAPEUTICS PHARMA, INC.; WANASKI, Stephen; COLLINS, Stephen; KINCAID, John Patent: WO2012/18635 A2, 2012 ; WO 2012/018635 A2 |
|
~%
methyl 3-[[[(di... CAS#:60376-73-0 |
| Literature: NEUROTHERAPEUTICS PHARMA, INC.; WANASKI, Stephen; COLLINS, Stephen; KINCAID, John Patent: WO2012/18635 A2, 2012 ; WO 2012/018635 A2 |
|
~%
methyl 3-[[[(di... CAS#:60376-73-0 |
| Literature: NEUROTHERAPEUTICS PHARMA, INC.; WANASKI, Stephen; COLLINS, Stephen; KINCAID, John Patent: WO2012/18635 A2, 2012 ; WO 2012/018635 A2 Title/Abstract Full Text Show Details NEUROTHERAPEUTICS PHARMA, INC.; WANASKI, Stephen, P.; COLLINS, Stephen, D.; KINCAID, John; DODSON, Gary, Steven Patent: WO2013/59648 A1, 2013 ; |
| HS Code | 2935009090 |
|---|---|
| Summary | 2935009090 other sulphonamides VAT:17.0% Tax rebate rate:9.0% Supervision conditions:none MFN tariff:6.5% General tariff:35.0% |
| methyl 3-({[(dimethylamino)methylene]amino}sulfonyl)-5-nitro-4-phenoxybenzoate |
| 3-nitro-4-phenoxy-5-N,N-dimethylaminomethyleneaminosulphonyl-benzoic acid methyl ester |
| 3-(dimethylaminomethylenesulfamoyl)-5-nitro-4-phenoxybenzoic acid methyl ester |
| Methyl 3-((((dimethylamino)methylene)amino)sulphonyl)-5-nitro-4-phenoxybenzoate |